InAADR

Drug Information

Drug Name: moclobemide (71320-77-9)
PubChem ID: 4235
SMILES: C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl
InchiKey: YHXISWVBGDMDLQ-UHFFFAOYSA-N
Therapeutic Category: Antidepressive Agents, Central Nervous System Agents, Enzyme Inhibitors, Monoamine Oxidase Inhibitors, Psychotropic Drugs

Computed Drug Properties

Molecular Weight (dalton): 268.744
LogP: 1.402
Ring Count: 1
Hydrogen Bond Acceptor Count: 3
Hydrogen Bond Donor Count: 1
Total Polar Surface Area: 41.57

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference
Rizatriptan (145202-66-0) Dizziness Synergistic MAO-A is the principal enzyme concerned with the metabolism of rizatriptan. Moclobemide inhibits this enzyme and therefore raises rizatriptan levels The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers
Rizatriptan (145202-66-0) Nausea Synergistic MAO-A is the principal enzyme concerned with the metabolism of rizatriptan. Moclobemide inhibits this enzyme and therefore raises rizatriptan levels The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers
Rizatriptan (145202-66-0) Somnolence Synergistic MAO-A is the principal enzyme concerned with the metabolism of rizatriptan. Moclobemide inhibits this enzyme and therefore raises rizatriptan levels The effects of moclobemide on the pharmacokinetics of the 5-HT1B/1D agonist rizatriptan in healthy volunteers

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abnormal Lfts MetaADEDB
Abuse MetaADEDB
Accident MetaADEDB
Administration Site Pain MetaADEDB
Adrenal Neoplasm MetaADEDB
Alanine Aminotransferase Increased MetaADEDB
Alcohol Abuse MetaADEDB
Allergic Dermatitis MetaADEDB
Anaemia MetaADEDB
Anaesthesia MetaADEDB
Anal Candidiasis MetaADEDB
Androgen Deficiency MetaADEDB
Anorexia MetaADEDB
Anticholinergic Syndrome MetaADEDB
Apathy MetaADEDB
Aptyalism MetaADEDB
Arthritis MetaADEDB
Asthma MetaADEDB
Ataxia MetaADEDB
Atrioventricular Block First Degree MetaADEDB
Attempted Suicide MetaADEDB
Benign Breast Neoplasm MetaADEDB
Bipolar Disorder MetaADEDB
Blood Glucose Abnormal MetaADEDB
Blood Ph Decreased MetaADEDB
Blood Prolactin Increased MetaADEDB
Blurred Vision MetaADEDB
Breast Calcifications MetaADEDB
Breast Cancer Stage Ii MetaADEDB
Breast Dysplasia MetaADEDB
Bronchial Disorder MetaADEDB
Candidiasis Of Vagina MetaADEDB
Carcinoid Syndrome MetaADEDB
Cardiogenic Shock MetaADEDB
Catheter Site Haematoma MetaADEDB
Cerebrovascular Spasm MetaADEDB
Clonus MetaADEDB
Colonoscopy MetaADEDB
Coma MetaADEDB
Complicated Migraine MetaADEDB
Confabulation MetaADEDB
Convulsion MetaADEDB
Corneal Reflex Decreased MetaADEDB
Csf Protein Increased MetaADEDB
Cutaneous Candidiasis MetaADEDB
Depressive Disorder MetaADEDB
Depressive Disorder Major MetaADEDB
Dermographism MetaADEDB
Diaphragmatic Paralysis MetaADEDB
Diarrhea MetaADEDB
Disseminated Intravascular Coagulation MetaADEDB
Drowsiness MetaADEDB
Drug Abuser MetaADEDB
Drug Interaction MetaADEDB
Drug Screen Positive MetaADEDB
Drug Toxicity MetaADEDB
Dysgeusia MetaADEDB
Dyspnea Exertional MetaADEDB
Electrocardiogram Qrs Complex Abnormal MetaADEDB
Electrocardiogram Qt Corrected Interval Prolonged MetaADEDB
Emesis MetaADEDB
Epistaxis MetaADEDB
Euphoric Mood MetaADEDB
Fasciitis MetaADEDB
Fatigue MetaADEDB
Feeding Disorder MetaADEDB
Foetal Growth Retardation MetaADEDB
Haematoma MetaADEDB
Hallucinations MetaADEDB
Heart Arrest MetaADEDB
Hepatic Congestion MetaADEDB
Hyperhidrosis MetaADEDB
Hyperreflexia MetaADEDB
Hypertension MetaADEDB
Hypertonia MetaADEDB
Hypotension MetaADEDB
Hypothermia MetaADEDB
Inappropriate Schedule Of Drug Administration MetaADEDB
Intentional Self-Injury MetaADEDB
Intestinal Polyp MetaADEDB
Lacunar Infarction MetaADEDB
Laryngeal Disorder MetaADEDB
Libido Increased MetaADEDB
Light Sensitivity MetaADEDB
Long Qt Syndrome MetaADEDB
Loss Of Weight MetaADEDB
Malignant Neoplasm Progression MetaADEDB
Mental Disorders MetaADEDB
Monarthritis MetaADEDB
Mouth Bleeding MetaADEDB
Multi-Organ Failure MetaADEDB
Multiple Drug Overdose MetaADEDB
Multiple Drug Overdose Intentional MetaADEDB
Nausea MetaADEDB
Oestrogen Receptor Assay Positive MetaADEDB
Overdose MetaADEDB
Oxygen Saturation Decreased MetaADEDB
Panic Attack MetaADEDB
Paraesthesia Oral MetaADEDB
Patellofemoral Pain Syndrome MetaADEDB
Poisoning MetaADEDB
Potentiating Drug Interaction MetaADEDB
Pre-Eclampsia MetaADEDB
Premature Labour MetaADEDB
Progesterone Receptor Assay MetaADEDB
Psychoses MetaADEDB
Pulmonary Alveolar Haemorrhage MetaADEDB
Pulmonary Arrest MetaADEDB
Pulmonary Congestion MetaADEDB
Pupillary Reflex Impaired MetaADEDB
Risus Sardonicus MetaADEDB
Self-Injurious Ideation MetaADEDB
Serotonin Syndrome MetaADEDB
Sexual Dysfunctions Psychological MetaADEDB
Sinus Bradycardia MetaADEDB
Sleep Initiation And Maintenance Disorders MetaADEDB
Small Cell Lung Cancer Extensive Stage MetaADEDB
Small For Dates Baby MetaADEDB
Spinning Sensation MetaADEDB
Swollen Tongue MetaADEDB
Tachycardia Ventricular MetaADEDB
Throat Tightness MetaADEDB
Tracheal Disorder MetaADEDB
Transient Ischaemic Attack MetaADEDB

InAADR: Drug-Protein-ADRs database